These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

590 related items for PubMed ID: 25862300

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Development of a hydrogen peroxide-inactivated vaccine that protects against viscerotropic yellow fever in a non-human primate model.
    Amanna IJ, Thomas A, Engelmann F, Hammarlund E, Raué HP, Bailey AL, Poore EA, Quintel BK, Lewis AD, Axthelm MK, Johnson AL, Colgin LMA, Diamond MS, Messaoudi I, Slifka MK.
    Cell Rep Med; 2024 Jul 16; 5(7):101655. PubMed ID: 39019010
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Duration of immunity in recipients of two doses of 17DD yellow fever vaccine.
    Collaborative group for studies on yellow fever vaccinesDepartament of Epidemiology and Quantitative Methods in Health, Escola Nacional de Saúde Pública, FIOCRUZ, Rua Leopoldo Bulhões, 1480, Sala 803. Manguinhos, Rio de Janeiro-RJ 21041-210, Brazil..
    Vaccine; 2019 Aug 14; 37(35):5129-5135. PubMed ID: 31171393
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Neurovirulence tests of three 17D yellow fever vaccine strains.
    Minor PD.
    Biologicals; 2011 May 14; 39(3):167-70. PubMed ID: 21536454
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Lymphocyte subset analyses in healthy adults vaccinated with yellow fever 17DD virus.
    Santos AP, Bertho AL, Dias DC, Santos JR, Marcovistz R.
    Mem Inst Oswaldo Cruz; 2005 May 14; 100(3):331-7. PubMed ID: 16113878
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Evidence for interferon production and its correlation with YF 17DD vaccine virus yields in primary chick embryo cells.
    Caride E, Borges MB, Marcovistz R, Galler R, Freire Mda S.
    Virus Res; 2008 Oct 14; 137(1):106-11. PubMed ID: 18621087
    [Abstract] [Full Text] [Related]

  • 39. Immunogenicity and duration of protection after yellow fever vaccine in people living with human immunodeficiency virus: a systematic review.
    Martin C, Domingo C, Bottieau E, Buonfrate D, De Wit S, Van Laethem Y, Dauby N.
    Clin Microbiol Infect; 2021 Jul 14; 27(7):958-967. PubMed ID: 33813107
    [Abstract] [Full Text] [Related]

  • 40. Persistence of yellow fever virus-specific neutralizing antibodies after vaccination among US travellers.
    Lindsey NP, Horiuchi KA, Fulton C, Panella AJ, Kosoy OI, Velez JO, Krow-Lucal ER, Fischer M, Staples JE.
    J Travel Med; 2018 Jan 01; 25(1):. PubMed ID: 30346562
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.